Question

A. Panel of widely recognized patient safety experts

a. Nurses, physicians, pharmacists, risk managers, clinical engineers, other professionals
B. They have hands-on experience in addressing patient safety issues in wide variety of health care settings.
C. The Patient Safety Advisory Group advises The Joint Commission on the development and updating of NPSGs.
D. Advises The Joint commission how to address emerging patient safety issues.
a. Ex. NPSG's, Sentinel Events Alerts, standards and survey processes, performance measures, educational materials, Center for Transforming Healthcare projects
E. Evaluate safety concerns and determine which ones will have the max impact for the minimum cost

Answer 1

The Patient Safety Advisory Group advises The Joint Commission on patient safety, while human factor professionals and pharmacovigilance systems play vital roles in ensuring healthcare and drug safety respectively.

Step-by-step explanation:

The Patient Safety Advisory Group is a panel of patient safety experts, including professionals such as nurses, physicians, and pharmacists, among others. This multidisciplinary team brings hands-on experience in managing patient safety issues across a variety of healthcare settings. They play a critical role in advising The Joint Commission, which is responsible for accrediting and certifying thousands of healthcare organizations in the United States. The group provides guidance on various patient safety initiatives such as the National Patient Safety Goals (NPSGs), Sentinel Event Alerts, and the development of educational materials.

Moreover, human factor professionals contribute to the safety and efficacy of healthcare delivery by ensuring that design processes incorporate ergonomics and usability, in efforts to prevent incidents like the Three Mile Island nuclear accident. They play a pivotal role in the creation of regulations and design principles that prioritize work safety.

In the realm of pharmaceuticals, pharmacovigilance systems are crucial for monitoring the long-term safety of newly approved drugs, by continuing to evaluate their effects as they are prescribed to a larger and more diverse patient population. This ongoing process is essential to ensure that any potential risks are identified and managed promptly.